U.S. Household Products Stock News

NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Berkshire Hathaway (BRK.A) Margin Drop Challenges Long‑Held Earnings Resilience Narrative

Berkshire Hathaway (BRK.A) has wrapped up FY 2025 with fourth quarter revenue of US$94.2b and net income of US$19.2b, translating to basic EPS of US$13,349.11, against FY 2024’s fourth quarter revenue of US$94.9b, net income of US$19.7b and EPS of US$13,695.19. Looking across recent periods, revenue has ranged from US$89.7b to US$95.0b per quarter through FY 2025, while basic EPS has moved between US$3,200.48 and US$21,412.53. This gives investors a wide earnings range to factor into their...
NasdaqCM:ASTH
NasdaqCM:ASTHHealthcare

Astrana Health (ASTH) Margins Stay Near 1% And Test Bullish Earnings Narratives

Astrana Health (ASTH) has wrapped up FY 2025 with fourth quarter revenue of US$950.5 million and basic EPS of US$0.12, alongside trailing twelve month revenue of US$3.2 billion and EPS of US$0.46 that frame the latest numbers in a wider earnings context. The company has seen revenue move from US$665.2 million and basic EPS of a US$0.15 loss in Q4 2024 to US$950.5 million and basic EPS of US$0.12 in Q4 2025. Trailing net profit margin of 0.7% sits well below last year’s 2.1%, so investors are...
NasdaqGS:SATS
NasdaqGS:SATSMedia

EchoStar (SATS) Deep FY 2025 Losses Reinforce Bearish Profitability Concerns

EchoStar (SATS) has just posted its FY 2025 numbers, with Q4 revenue of US$3.8b and a basic EPS loss of US$4.19, alongside a full year trailing EPS loss of US$50.41 on revenue of US$15.0b and trailing net income losses of US$14.5b. Over recent periods the company has seen quarterly revenue move from US$3.9b in Q4 2024 to US$3.6b in Q3 2025 and US$3.8b in Q4 2025, while EPS shifted from a profit of US$1.19 in Q4 2024 to losses of US$44.37 in Q3 2025 and US$4.19 in Q4 2025. This puts a clear...
NYSE:ADT
NYSE:ADTConsumer Services

ADT (ADT) Q3 Earnings Highlight 12.7% Net Margin That Fuels Bullish Valuation Narratives

ADT (ADT) has just posted its FY 2025 third quarter results, with revenue of about US$1.3 billion and basic EPS of roughly US$0.18, alongside trailing 12 month EPS of about US$0.77 and revenue of roughly US$5.1 billion that frame the latest quarter in a wider earnings context. Over recent periods the company has seen revenue move from about US$1.20 billion in Q2 FY 2024 to roughly US$1.30 billion in Q3 FY 2025, while quarterly EPS has ranged between about US$0.14 and US$0.22. This gives...
NYSE:BH.A
NYSE:BH.AHospitality

Biglari Holdings (BH.A) Net Margin Collapse To 0.5% Tests Bullish Narratives

Biglari Holdings (BH.A) has just posted a mixed set of FY 2025 Q3 numbers, with revenue at US$99.7 million and a basic EPS loss of US$20.38. This follows earlier quarters that swung from a basic EPS loss of US$126.40 in Q1 on US$95.0 million of revenue to a basic EPS of US$194.57 in Q2 on US$100.6 million of revenue. Over the last year, the company has seen trailing twelve month revenue move in a tight band between US$361.7 million and US$386.5 million. Over the same period, basic EPS has...
NYSE:NCLH
NYSE:NCLHHospitality

Norwegian Cruise Line (NCLH) Q3 EPS Rebound Tests Bullish Earnings Growth Narrative

Norwegian Cruise Line Holdings (NCLH) has reported solid numbers for FY 2025 so far, with Q3 revenue of US$2.9b and basic EPS of US$0.93, backed by trailing twelve month EPS of US$1.49 on revenue of US$9.7b. The company’s quarterly revenue moved from US$2.1b in Q4 2024 to US$2.1b in Q1 2025, US$2.5b in Q2 and US$2.9b in Q3, while quarterly EPS shifted from US$0.58 to a loss of US$0.09, then US$0.07 and US$0.93. This creates a backdrop where investors are focused on how stable margins really...
NYSE:TGNA
NYSE:TGNAMedia

Tegna (TGNA) Earnings Slide And Margin Compression Reinforce Bearish Profitability Narratives

Tegna (TGNA) has laid out its FY 2025 scorecard so far with Q3 revenue of US$650.8 million and basic EPS of US$0.23, alongside trailing twelve month revenue of about US$2.9 billion and EPS of US$2.13 that sit against a net profit margin of 11.9%. The company has seen quarterly revenue move from US$710.4 million in Q2 2024 to US$675.0 million in Q2 2025, with EPS shifting from US$0.48 to US$0.42 over the same period, as trailing earnings also reflect a one off US$139.1 million gain that shapes...
NYSE:VG
NYSE:VGOil and Gas

Venture Global (VG) Net Margin At 19% Challenges Bearish Profitability Narratives

Venture Global FY 2025 Earnings Snapshot Venture Global (VG) has put fresh numbers on the board for FY 2025, with third quarter revenue of about US$3.3b and basic EPS of US$0.18, setting the tone for how the rest of the year will be judged. The company has seen revenue move from US$926m in Q3 2024 to US$3.3b in Q3 2025. Basic EPS shifted from a loss of US$0.15 in Q3 2024 to a profit of US$0.18, and trailing twelve month EPS reached US$0.86 on revenue of about US$10.8b. With trailing net...
NYSE:MTG
NYSE:MTGDiversified Financial

Is MGIC Investment (MTG) Quietly Rewriting Its Edge Through Market Share Gains And Tech Spending?

MGIC Investment Corporation’s recently filed 2025 Form 10-K shows past-year growth in insurance in force and market share, supported by reinsurance and capital management actions. The filing also highlights how technology and innovation spending is being used alongside disciplined pricing and risk controls to sustain MGIC’s competitive position despite pressure on premium volumes. We’ll now examine how MGIC’s market share gains and technology investment may reshape its existing investment...
NasdaqGS:EFSC
NasdaqGS:EFSCBanks

Will EFSC’s Branch Expansion, Capital Returns and Debt Moves Reshape Enterprise Financial Services’ Core Narrative?

Enterprise Financial Services Corp recently filed its 2025 Form 10-K, outlining its past-year performance, the acquisition of 12 First Interstate Bank branches in Arizona and Kansas City, higher quarterly dividends, share repurchases, and balance sheet actions including subordinated debt redemption and a lower-cost senior note issuance. An interesting insight from the filing is how the combination of branch purchases, capital returns, and debt refinancing reflects management’s emphasis on...
NYSE:TPB
NYSE:TPBTobacco

Turning Point Brands (TPB) Margin Compression Tests Bullish Growth Narrative After Q3 Earnings

Turning Point Brands (TPB) has reported third quarter FY 2025 revenue of US$119 million and basic EPS of US$1.16, with trailing twelve month revenue at US$436 million and basic EPS of US$3.31. The company has seen quarterly revenue move from US$90.7 million in the third quarter of 2024 to US$119 million in the third quarter of 2025, while quarterly basic EPS went from US$0.71 to US$1.16 over the same span. This sets up a story where higher recent earnings meet a shift in net profit margins...
NasdaqGS:KC
NasdaqGS:KCIT

Evaluating Kingsoft Cloud Holdings (NasdaqGS:KC) After Higher Related Party Lease Caps Raise Fixed Cost Concerns

Kingsoft Cloud Holdings (NasdaqGS:KC) recently raised the annual caps on related-party property services and lease transactions with Kingsoft Corporation for 2026 and 2027, prompting a roughly 6% share price drop as investors assessed higher fixed cost exposure. See our latest analysis for Kingsoft Cloud Holdings. The latest announcement comes after a period of mixed performance, with a 17.3% year to date share price return but a 14.3% decline in 1 year total shareholder return, while the 3...
NasdaqCM:CGEN
NasdaqCM:CGENBiotechs

Compugen (CGEN) Quarterly Loss Near US$7 Million Tests Bullish Profitability Narrative

Compugen (CGEN) has just reported its FY 2025 results, with Q3 revenue of US$1.9 million and a basic EPS loss of US$0.07. Trailing twelve month figures show revenue of US$6.9 million and a basic EPS loss of US$0.30. The company has seen quarterly revenue range from US$1.3 million to US$2.3 million in FY 2025 so far, with basic EPS losses between US$0.07 and US$0.08 over the same stretch. This sets up a picture in which top line consistency still sits alongside negative earnings. With revenue...
NYSE:HNGE
NYSE:HNGEHealthcare

Assessing Hinge Health’s Valuation After A Recent Share Price Rebound

What Hinge Health’s latest trading move signals for investors Hinge Health (HNGE) has caught investor attention after a recent move in its share price, with the stock closing at US$42.76 as short term returns and fundamentals offer a mixed picture. See our latest analysis for Hinge Health. The recent 7 day share price return of 11.21% and 30 day share price return of 22.52% sit against a weaker 90 day share price return of 8.16% and year to date share price return of 6.15%. This suggests...
NYSE:RLJ
NYSE:RLJHotel and Resort REITs

A Look At RLJ Lodging Trust (RLJ) Valuation After Strong Q4 Results And Continued Capital Returns

RLJ Lodging Trust (RLJ) shares are in focus after the company posted above-consensus fourth quarter results, highlighting stronger urban hotel performance, higher non-room revenue, active property conversions, and increased balance sheet flexibility from recent refinancing. See our latest analysis for RLJ Lodging Trust. At a share price of US$8.02, RLJ Lodging Trust has seen short term momentum pick up, with a 30 day share price return of 7.94% and a 90 day gain of 8.23%. This comes even...
NasdaqGS:GTM
NasdaqGS:GTMInteractive Media and Services

What ZoomInfo Technologies (GTM)'s AI Pivot and $1 Billion Buyback Plan Means For Shareholders

In recent days, ZoomInfo Technologies reported that its upmarket customers now account for 74% of its business, Copilot AI has reached 20% of annual contract value, and the company approved an additional US$1.00 billion for share repurchases while providing cautious 2026 revenue guidance. At the same time, supportive comments from Nvidia CEO Jensen Huang about AI complementing enterprise software reframed how investors view ZoomInfo’s AI-focused evolution. We’ll now examine how Nvidia’s...
NasdaqGS:OPCH
NasdaqGS:OPCHHealthcare

Option Care Health (OPCH) Valuation After 2025 Results And Expanded Share Repurchase Program

Option Care Health (OPCH) shares came into focus after the company reported fourth quarter and full year 2025 results, combining higher sales with margin pressure from biosimilar adoption, reaffirmed guidance and a larger share repurchase program. See our latest analysis for Option Care Health. At a share price of US$32.46, Option Care Health has seen pressure recently, with a 7 day share price return of a 10.06% decline and a 1 month share price return of a 4.53% decline. This is in contrast...
NYSE:ESAB
NYSE:ESABMachinery

How ESAB’s Mixed Q4, New Dividend and Welding Launch Could Impact ESAB (ESAB) Investors

ESAB Corporation recently reported fourth-quarter 2025 results showing higher sales but lower earnings year-on-year, while its Board affirmed a quarterly cash dividend of US$0.10 per share payable on April 17, 2026. Alongside this, increased institutional ownership and the launch of the Ruffian EMP 270G welding generator signal growing interest in ESAB’s product portfolio and income-return profile. With ESAB maintaining its dividend and enhancing its welding offering, we’ll now examine how...
NYSE:SSD
NYSE:SSDBuilding

How New Ohio and Tennessee Plants and 50 Products Will Impact Simpson Manufacturing (SSD) Investors

Simpson Manufacturing recently detailed in its 2025 10-K that it has opened new production facilities in Columbus, Ohio, and Gallatin, Tennessee, while launching over 50 new products across wood, mass timber, and concrete construction categories. This combination of expanded in-house manufacturing and a broad wave of product development highlights how Simpson is reshaping its cost base and deepening its role in structural building solutions. Next, we’ll examine how these new Ohio and...
NYSE:CRS
NYSE:CRSAerospace & Defense

Carpenter Technology CEO Succession Plan Meets Strong Share Price Momentum

Carpenter Technology (NYSE:CRS) has outlined a CEO succession plan with Brian Malloy scheduled to become Chief Executive Officer on July 1, 2026. Current CEO Tony Thene is expected to transition to the role of Executive Chairman as part of the planned leadership change. Malloy brings operational experience at Carpenter Technology and prior industry leadership that may influence future company priorities. Carpenter Technology enters this planned leadership transition with its shares at...
NYSE:AVY
NYSE:AVYPackaging

Will Stricter Shareholder Disclosures Reshape Avery Dennison's (AVY) Governance Narrative and Investor Engagement?

On February 26, 2026, Avery Dennison’s board approved amended and restated bylaws that, among other changes, require shareholders to disclose any material interest in business they propose for stockholder meetings. The bylaw overhaul, which also tightens disclosure around shareholder proposals and director nominations, could meaningfully affect how actively engaged investors interact with the company’s board. We’ll now examine how this added shareholder disclosure requirement may influence...
NYSE:UCB
NYSE:UCBBanks

Does United Community Banks' Dividend Amid Credit Concerns Reveal Its True Risk Appetite (UCB)?

United Community Banks, Inc. previously announced that its Board approved a quarterly cash dividend of US$0.25 per share, payable on April 3, 2026 to shareholders of record as of March 13, 2026. The dividend decision underscores the bank’s ongoing commitment to returning cash to shareholders even as regional lenders face heightened scrutiny over credit risk and loan quality. Next, we’ll examine how this routine dividend declaration interacts with rising credit risk concerns to shape United...
NasdaqGS:FRME
NasdaqGS:FRMEBanks

Should Merger Expansion, Dividends, and Insider Selling Amid Credit Jitters Require Action From First Merchants (FRME) Investors?

In recent days, First Merchants Corporation completed its acquisition of First Savings Financial Group, continued investing in digital and community initiatives, declared both common and preferred dividends, and saw Director and First Vice President Larry W. Myers sell 5,000 shares, all against a backdrop of renewed concern about regional banks’ credit risk following hotter-than-expected inflation data. This combination of a completed merger that expands the bank’s southern Indiana...
NasdaqGS:BCRX
NasdaqGS:BCRXBiotechs

BioCryst Pharmaceuticals (BCRX) Is Up 15.4% After First Profitable Year And HAE Portfolio Expansion - Has The Bull Case Changed?

In late February 2026, BioCryst Pharmaceuticals reported fourth-quarter 2025 revenue of US$406.56 million and net income of US$245.85 million, capping its first full year of profitability with US$874.84 million in revenue and US$263.86 million in net income. The move into sustained profitability, underpinned by strong ORLADEYO performance and the Astria Therapeutics acquisition that broadened its hereditary angioedema portfolio, marks a step-change in BioCryst’s financial and competitive...